Beneficient Closes $7.44 Million GP Primary Capital Transaction
Rhea-AI Summary
Beneficient (NASDAQ: BENF) closed a $7.44 million GP primary capital transaction with Quartus AI Fund II LP, managed by Quartus Capital Partners. The fund received approximately $7.44 million in stated value of Beneficient resettable convertible preferred stock, convertible into Class A common shares under agreed terms.
The commitment scales with the fund’s total commitments, up to $26.25 million if the fund reaches its $150 million target. The transaction is expected to add about $7.44 million of alternative asset collateral to Beneficient’s ExAlt loan portfolio and increase tangible book value attributable to public stockholders by roughly $7.44 million. Year-to-date GP primary transactions have contributed about $17.2 million of tangible book value attributable to stockholders. Pro forma for year-to-date transactions, tangible book value remains negative at about $(91.46) million, versus total market capitalization of approximately $50.6 million as of July 10, 2026.
Positive
- $7.44m GP primary capital commitment to Quartus AI Fund II LP
- Potential commitment expansion up to $26.25m if fund hits $150m target
- Transaction expected to add about $7.44m collateral to ExAlt loan portfolio
- Tangible book value attributable to public stockholders +$7.44m pro forma for this transaction
- YTD GP primary transactions add about $17.2m tangible book value attributable to stockholders
Negative
- Issuance of $7.44m resettable convertible preferred stock implies potential future dilution
- Pro forma YTD tangible book value remains negative at about $(91.46)m
- Total equity (deficit) still negative at about $(172.07)m pro forma YTD
- Equity deficit materially exceeds market capitalization of about $50.65m as of July 10, 2026
News Explained
The transaction adds $7.44 million of pro forma tangible book value, while conversion-related ownership effects remain unquantified.
On
As consideration for Beneficient’s interest in the fund, the fund received approximately
The Preferred Stock is convertible at the holder’s election into Class A common stock under the transaction documents, but the release does not provide a share count or conversion ratio, so the ownership effect on existing common holders cannot be sized from this disclosure. Beneficient expects the transaction to add approximately
At
Sources and calculations
- Beneficient Closes $7.44 Million GP Primary Capital Transaction (2026-07-13)
- Beneficient fourth-quarter fundamentals (2026Q4)
- Cash and equivalents vs quarterly operating cash outflow, in days of cash use $2,543,000 / ($3,980,000 / 90) = [object Object]
News Market Reaction – BENF
In the Jul 14 session, BENF declined 9.21%, reflecting a notable negative market reaction. Argus tracked a trough of -19.9% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. Trading volume was above average at 1.8x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 29 | Shareholder letter | Positive | -4.9% | Letter detailed progress on GWG issues, asset sales and AI-driven growth. |
| Jun 29 | Earnings report | Negative | -4.9% | Fiscal 2026 results with high expenses, litigation costs and low cash levels. |
| Jun 25 | New services deal | Positive | +4.5% | First collateral management mandate expected to generate recurring fee revenue. |
| May 11 | Legal update | Neutral | -4.7% | Statement on former CEO’s conviction and implications for related claims. |
| Apr 10 | GP capital deal | Positive | +10.3% | Closed $8.75M GP primary capital transaction with Quartus AI Fund LP. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
BENF’s GP primary capital deals have previously coincided with positive stock reactions, whereas broader corporate or legal updates have often seen negative follow-through.
Key Terms
resettable convertible preferred stock financial
tangible book value financial
market capitalization financial
beneficial ownership cap regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
DALLAS, July 13, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of a
The Transaction reflects continued momentum for the Company’s GP Primary Commitment Program and further execution of its strategy to provide primary capital solutions to qualifying private investment funds, while marking Beneficient’s second GP primary capital transaction this year with an AI-focused fund managed by Quartus. As consideration for the Company’s interest in the Fund, the Fund received approximately
The Transaction is expected to increase the collateral for the Company’s ExAlt loan portfolio by approximately
“We are pleased to expand our relationship with Quartus by closing this Transaction with a second AI-focused fund that Quartus manages,” said James Silk, Beneficient CEO. “Artificial intelligence continues to be one of the most dynamic and actively expanding areas of the global technology market, and we are excited that our GP Primary Commitment Program provides Beneficient with a pathway to participate in that growth through exposure to differentiated AI-focused private investment funds. The Company will continue to pursue transactions that we believe can drive shareholder value, strengthen the collateral backing our ExAlt loan portfolio, and expand Beneficient’s exposure to high-growth areas of the private markets.”
The Fund is expected to target growth stage AI-based and AI-enabled companies that generate at least
Beneficient’s GP Primary Commitment Program is focused on providing primary capital solutions and financing anchor commitments to general partners during their fundraising efforts while immediately deploying capital into our equity. Through the program, Beneficient seeks to help satisfy the up to
Reconciliation of Non-GAAP Financial Measures
The following tables reconcile these non-GAAP financial measures to the most comparable GAAP financial measures as of March 31, 2026, on an actual basis and pro forma assuming the Transaction occurred on March 31, 2026, and pro forma giving effect to the Company’s GP Primary capital transactions completed during this fiscal year.
| (dollars in thousands) | Actual | Pro forma – Transaction | Pro forma – YTD transactions | |||||
| Tangible Book Value | ||||||||
| Total equity (deficit) | (189,286 | ) | (181,842 | ) | (172,072 | ) | ||
| Less: Goodwill | (9,914 | ) | (9,914 | ) | (9,914 | ) | ||
| Plus: Total temporary equity | 90,526 | 90,526 | 90,526 | |||||
| Tangible book value | (108,674 | ) | (101,230 | ) | (91,460 | ) | ||
| Actual | Pro forma – Transaction | Pro forma – YTD transactions | ||||||
| Tangible book value attributable to public company stockholders | ||||||||
| Tangible book value | (108,674 | ) | (101,230 | ) | (91,460 | ) | ||
| Less: Tangible book value attributable to Beneficient Holdings noncontrolling interest holders | (108,674 | ) | (108,674 | ) | (108,674 | ) | ||
| Tangible book value attributable to Ben’s public company stockholders | — | 7,444 | 17,214 | |||||
| Market Capitalization of Ben’s Class A and Class B common stock as of July 10, 2026 (1) | ||||||||
(1) Based upon the closing price of the Class A common stock as reported by Nasdaq as of market close on July 10, 2026.
About Beneficient
Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and preferred liquidity services for their funds − with solutions that could help them unlock the value in their alternative assets.
Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.
For more information, visit www.trustben.com or follow us on LinkedIn.
Contacts
Matt Kreps: 214-597-8200, mkreps@darrowir.com
Michael Wetherington: 214-284-1199, mwetherington@darrowir.com
Investor Relations: investors@beneficient.com
Important Information and Where You Can Find It
This press release may be deemed to be solicitation material in respect of a vote of stockholders to approve the issuance of the Company’s Class A common stock upon conversion of the Preferred Stock. In connection with the requisite stockholder approval, Ben will file with the Securities and Exchange Commission (the “SEC”) a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of Ben, seeking such approvals related to the Transaction.
INVESTORS AND SECURITY HOLDERS OF BEN AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT BEN AND THE TRANSACTION. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about Ben, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by Ben can also be obtained, without charge, by directing a request to Investor Relations, Beneficient, 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201, or email investors@beneficient.com.
Participants in the Solicitation of Proxies in Connection with Transaction
Ben and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding Ben’s directors and executive officers is available in its annual report on Form 10-K for the fiscal year ended March 31, 2026, which was filed with the SEC on June 30, 2026 and certain current reports on Form 8-K filed by Ben. Other information regarding the participants in the solicitation of proxies with respect to the Transaction and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.
Not an Offer of Securities
The information in this communication is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the Transaction have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Forward Looking Statements
Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the Transaction, the expected benefits of the Transaction, the expected increase in collateral for the Company’s ExAlt loan portfolio, the expected addition to tangible book value attributable to the Company’s stockholders, the Fund’s investment strategy and potential performance, growth, and investment risks. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.
Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others: the ultimate outcome of the Transaction, and the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.
Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
